The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...
In the first episode of The Deep End Podcast, we meet Jon Nelson, who shares why he volunteered to get brain implants for his relentless depression.
"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat ... an intranasal formulation of racemic ketamine. Bain Capital has agreed to buy Mitsubishi ...
Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...
As the Washington Post reports, 36-year-old DOGE lackey Alexandra Beynon previously spent her days as head of engineering at the online ketamine therapy company Mindbloom before taking a new gig ...
Baby boomers had LSD, Gen X had pills and millennials had cocaine. So could ketamine be Gen Z's drug of choice? The latest government figures show that the drug's usage among 16-24 year olds in ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
Before rehabilitation (left), Casey Innalls was using ketamine every day Every generation seems to have an association with an illegal drug. Baby boomers had LSD, Gen X had pills and millennials ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
OKAY, HONEY, COME SIT HERE. TODAY, JOE IS TESTING SOMETHING NEW. A MEDICATION CALLED FOR INSIDE THIS NASAL SPRAY. ONE, TWO. THREE. JOE IS THE FIRST PATIENT WITH ALZHEIMER’S TO TRY THIS DRUG.
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results